Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
Expansion of existing partnership will utilize novel insights into causal biology within auto-immune disorders to identify novel targets for drug ...
Stay updated with breaking news from Sosei Heptares. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Expansion of existing partnership will utilize novel insights into causal biology within auto-immune disorders to identify novel targets for drug ...
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - May 21, 2024 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first quarter of 2024. Business highlights Viatris
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - May 21, 2024Idorsia Ltd (SIX: IDIA) today announced its financial results for the full year of 2023. Business highlights Sale
Japan, South Korea, and the African subcontinent are now covered by the Alliance. With the addition of two new WODA members – Nxera Pharma (formerly Sosei Heptares) and Veld Pharmaceuticals – WODA now provides access to over 200 million rare disease patients. TOKYO and ZUG, Switzerland, April 08, 2024 (GLOBE NEWSWIRE) -- The World Orphan Drug Alliance (WODA), a global alliance of commercial distributors dedicated to providing access to treatments for rare diseases and specialty medicines in comp